6011000124106~MAPPRIORITY~4

6011000124106~MAPADVICE~IF GYNECOMASTIA CAUSED BY HUMAN CHORIONIC GONADOTROPHIN CHOOSE N62 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA

447562003~MAPADVICE~IF HUMAN CHORIONIC GONADOTROPHIN-INDUCED GYNECOMASTIA CHOOSE Y42.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | MAPPED FOLLOWING WHO GUIDANCE

6011000124106~MAPTARGET~

6011000124106~MAPCATEGORYID~447638001

6011000124106~MAPRULE~IFA 431498001 &#x7C; Idiopathic gynecomastia (disorder) &#x7C; AND IFA 445518008 &#x7C; Age at onset of clinical finding (observable entity) &#x7C; < 29.0 days

6011000124106~MAPRULE~IFA 163435004 &#x7C; On examination - gynecomastia (disorder) &#x7C;

6011000124106~MAPGROUP~1

6011000124106~MAPGROUP~2

447562003~MAPGROUP~2

447562003~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA

6011000124106~MAPRULE~IFA 431498001 &#x7C; Idiopathic gynecomastia (disorder) &#x7C;

900000000000508004~ACCEPTABILITYID~900000000000549004

6011000124106~MAPRULE~IFA 237449003 &#x7C; Gynecomastia caused by drug &#x7C;

447562003~MAPTARGET~N62

447562003~MAPGROUP~1

6011000124106~MAPADVICE~IF GYNECOMASTIA CAUSED BY DRUG CHOOSE T50.904? &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF HUMAN CHORIONIC GONADOTROPHIN-INDUCED GYNECOMASTIA CHOOSE T38.894? &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~CORRELATIONID~447561005

447562003~MAPRULE~OTHERWISE TRUE

6011000124106~MAPCATEGORYID~447637006

900000000000509007~ACCEPTABILITYID~900000000000548007

6011000124106~MAPADVICE~IF DRUG-INDUCED GYNECOMASTIA CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPRULE~IFA 237450003 &#x7C; Human chorionic gonadotrophin-induced gynecomastia (disorder) &#x7C;

6011000124106~MAPADVICE~IF ON EXAMINATION - GYNECOMASTIA AND IF AGE AT ONSET OF CLINICAL FINDING BEFORE 29.0 DAYS CHOOSE P83.4 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

900000000000508004~ACCEPTABILITYID~900000000000548007

447562003~MAPADVICE~IF HUMAN CHORIONIC GONADOTROPHIN-INDUCED GYNECOMASTIA CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPRULE~IFA 237449003 &#x7C; Drug-induced gynecomastia (disorder) &#x7C;

447562003~MAPTARGET~

6011000124106~MAPADVICE~IF HCG-INDUCED GYNECOMASTIA CHOOSE T38.894? &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPPRIORITY~1

447562003~MAPCATEGORYID~447637006

6011000124106~MAPTARGET~N62

6011000124106~MAPTARGET~T50.904?

447562003~MAPADVICE~IF DRUG-INDUCED GYNECOMASTIA CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT &#x7C; POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPRULE~IFA 237450003 &#x7C; HCG-induced gynecomastia &#x7C;

6011000124106~MAPRULE~OTHERWISE TRUE

6011000124106~MAPPRIORITY~5

6011000124106~MAPRULE~IFA 237449003 &#x7C; Drug-induced gynecomastia &#x7C;

6011000124106~MAPADVICE~IF ON EXAMINATION - GYNECOMASTIA CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPCATEGORYID~447639009

447562003~MAPRULE~IFA 237449003 &#x7C; Drug-induced gynecomastia (disorder) &#x7C;

6011000124106~MAPADVICE~IF PUBERTAL GYNECOMASTIA CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPPRIORITY~3

447562003~MAPTARGET~Y42.8

447562003~MAPCATEGORYID~447639009

6011000124106~MAPADVICE~ALWAYS N62

6011000124106~MAPRULE~IFA 237451004 &#x7C; Pubertal gynecomastia &#x7C;

6011000124106~MAPPRIORITY~1

6011000124106~MAPADVICE~IF GYNECOMASTIA CAUSED BY DRUG CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~CORRELATIONID~447561005

6011000124106~MAPRULE~IFA 445518008 &#x7C; Age at onset of clinical finding (observable entity) &#x7C; < 29.0 days

447562003~MAPPRIORITY~2

6011000124106~MAPTARGET~P83.4

6011000124106~MAPADVICE~IF DRUG-INDUCED GYNECOMASTIA CHOOSE T50.904? &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPADVICE~ALWAYS N62

6011000124106~MAPPRIORITY~3

6011000124106~MAPTARGET~T38.894?

900000000000509007~ACCEPTABILITYID~900000000000549004

6011000124106~MAPADVICE~IF HCG-INDUCED GYNECOMASTIA CHOOSE N62 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPRULE~IFA 237450003 &#x7C; Gynecomastia caused by human chorionic gonadotrophin &#x7C;

6011000124106~MAPADVICE~IF GYNECOMASTIA CAUSED BY HUMAN CHORIONIC GONADOTROPHIN CHOOSE T38.894? &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~2

6011000124106~MAPRULE~IFA 163435004 &#x7C; On examination - gynecomastia (disorder) &#x7C; AND IFA 445518008 &#x7C; Age at onset of clinical finding (observable entity) &#x7C; < 29.0 days

6011000124106~MAPADVICE~IF IDIOPATHIC GYNECOMASTIA AND IF AGE AT ONSET OF CLINICAL FINDING BEFORE 29.0 DAYS CHOOSE P83.4 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPCATEGORYID~447638001